The mRNA Therapeutics Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size for mRNA therapeutics has been experiencing a consistent growth recently. From $34.76 billion in 2024, it is projected to reach $36.25 billion in 2025, showcasing a compound annual growth rate (CAGR) of 4.3%.
The mRNA therapeutics market is predicted to grow to a size of $42.23 billion by the year 2029. This growth represents a compound annual growth rate (CAGR) of 3.9%.
Download Your Free Sample of the 2025 mRNA Therapeutics Market Report and Uncover Key Trends Now!The drivers in the mrna therapeutics market are:
• Financial support for developments in effective pharmaceuticals and vaccines
• Expansion of federal programs focused on the advancement of RNa-based medicines
• Increase in awareness regarding rare genetic diseases
• A rise in the number of clinical trials in mRNA therapeutics
The mRNA therapeutics market covered in this report is segmented –
1) By Product: Vaccines, Drugs
2) By Application: Infectious Diseases, Oncology, Rare Genetic Diseases, Respiratory Diseases, Other Applications
3) By End Use: Hospitals And Clinics, Research Organizations, Other End Uses
The trends in the mrna therapeutics market are:
• Advancements in mRNA delivery technologies are emerging as a key trend.
• Rapid development and adaptation of mRNA vaccines are expected to shape the market's future.
• The emergence of self-amplifying mRNA (saRNA) platforms is a significant upcoming trend.
• Scalability and flexibility in mRNA manufacturing, along with novel mRNA modifications development, are emerging trends.
The major players in the mrna therapeutics market are:
• Pfizer Inc.
North America was the largest region in the mRNA therapeutics market in 2024